Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome

NCT00043134 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

220

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions

DRUG: decitabine

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC